ImageneBio, Inc.
IMA· Nasdaq
Released Nov 12, 2025, before the open
10-Q filed Nov 12, 2025, 43 days after period end · 0001193125-25-275932
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $0.00 | $3.50M | $1.19M | $6.40M |
| Net Income | -$24.78M | -$3.18M | -$17.34M | -$17.34M |
| EPS Diluted |
ImageneBio, Inc. · CIK 1835579 · Engraved from SEC EDGAR
| -$2.91 |
| -$2.58 |
| -$0.40 |
| -$0.48 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.